AGREEMENT OF JOINT FILINGAgreement of Joint Filing • January 3rd, 2019 • Viking Global Investors Lp • Pharmaceutical preparations
This joint filing agreement (this “Agreement”) is made and entered into as of this 3rd day of January 2019, by and among Viking Global Investors LP, Viking Global Performance LLC, Viking Global Equities LP, Viking Global Equities II LP, VGE III Portfolio Ltd., Viking Global Equities Master Ltd., Viking Long Fund GP LLC, Viking Long Fund Master Ltd., Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
ContractJoint Filing Agreement • October 16th, 2023 • Viking Global Investors Lp • Laboratory analytical instruments
This joint filing agreement is made and entered into as of this 16th day of October, 2023, by and among Viking Global Investors LP, Viking Global Opportunities Parent GP LLC, Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, Viking Global Opportunities Drawdown GP LLC, Viking Global Opportunities Drawdown Portfolio GP LLC, Viking Global Opportunities Drawdown (Aggregator) LP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
COOPERATION AGREEMENT March 17, 2023Cooperation Agreement • March 21st, 2023 • Viking Global Investors Lp • Retail-auto dealers & gasoline stations
Reference is made to the Indenture dated as of February 16, 2022 (the “Indenture”), between Cazoo Group Ltd (the “Company”), as issuer, and U.S. Bank Trust Company, National Association (the “Trustee”), pursuant to which the Company issued $630.0 million aggregate principal amount of 2.00% Convertible Senior Notes due February 16, 2027 (the “Notes”). Capitalized terms used but not otherwise defined in this Cooperation Agreement (this “Agreement”) shall have the meanings assigned to such terms in the Indenture.
AGREEMENT OF JOINT FILINGAgreement of Joint Filing • October 10th, 2018 • Viking Global Investors Lp • Pharmaceutical preparations
This joint filing agreement (this “Agreement”) is made and entered into as of this 10th day of October 2018, by and among Viking Global Investors LP, Viking Global Performance LLC, Viking Global Equities LP, Viking Global Equities II LP, VGE III Portfolio Ltd., Viking Long Fund GP LLC, Viking Long Fund Master Ltd., Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
Viking Global Investors LPLetter Agreement • February 5th, 2024 • Viking Global Investors Lp • Retail-auto dealers & gasoline stations
This letter agreement (this “Agreement”) is made and entered into by and between Viking Global Investors LP, together with the funds, accounts and entities managed or advised (on a discretionary basis) by it from time to time (“Viking”) and Cazoo Group Ltd (the “Company”). Reference is made to that certain Investor Rights Agreement, dated December 6, 2023, by and among the Company and the Holders thereto (the “IRA”). As contemplated by Section 2.1.2 of the IRA, the Company shall take all Necessary Action (as defined in the IRA) to cause the appointments of one director to be designated by Viking at a later time following the closing of the transactions contemplated by the Transaction Support Agreement, dated September 20, 2023, by and among the Companies and the parties thereto, as amended.
TERMINATION AGREEMENTTermination Agreement • September 22nd, 2023 • Viking Global Investors Lp • Retail-auto dealers & gasoline stations • New York
Reference is made to the Cooperation Agreement, dated as of March 17, 2023 (as amended from time to time, the “Agreement”), by and among (i) Viking Global Equities Master Fund, Ltd. and Viking Global Equities II LP; (ii) Farallon Capital Europe LLP, for and on behalf of funds, accounts and/or entities managed or advised by it; (iii) Inherent ESG Opportunity Master, LP, Inherent Credit Opportunities Master, LP, and Inherent Private Opportunities 2021, LP; (iv) D1 Capital Partners Master LP; and (v) MIC Capital Management UK LLP, for and on behalf of funds, accounts and/or entities managed or advised by it, MIC Capital Management 38 RSC Ltd and 94th Investment Company LLC (each, a “Party” and, collectively, the “Parties”). Capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Agreement.
AGREEMENT OF JOINT FILINGAgreement of Joint Filing • July 8th, 2019 • Viking Global Investors Lp • Pharmaceutical preparations
This joint filing agreement (this “Agreement”) is made and entered into as of this 8th day of July 2019, by and among Viking Global Investors LP, Viking Global Performance LLC, Viking Global Equities LP, Viking Global Equities Master Ltd., Viking Long Fund GP LLC, Viking Long Fund Master Ltd., Viking Global Opportunities GP LLC, Viking Global Opportunities Portfolio GP LLC, Viking Global Opportunities Illiquid Investments Sub-Master LP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
EXHIBIT A - JOINT FILING AGREEMENTA - Joint Filing Agreement • March 12th, 2021 • Viking Global Investors Lp • Blank checks
This joint filing agreement is made and entered into as of this 12th day of March, 2021, by and among Viking Global Investors LP, Viking Global Performance LLC, Viking Global Equities II LP, Viking Global Equities Master Ltd., Viking Long Fund GP LLC, Viking Long Fund Master Ltd., O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
JOINDER TO COOPERATION AGREEMENTCooperation Agreement • April 27th, 2023 • Viking Global Investors Lp • Retail-auto dealers & gasoline stations • New York
THIS JOINDER (this “Joinder”) to the Cooperation Agreement, dated as of March 17, 2023 (the “Agreement”), by and among Viking Global Equities Master Fund, Ltd., Viking Global Equities II LP, Farallon Capital Europe LLP, for and on behalf of funds, accounts and/or entities managed or advised by it, Inherent ESG Opportunity Master, LP, Inherent Credit Opportunities Master, LP, and Inherent Private Opportunities 2021, LP (each, an “Original Party” and collectively, the “Original Parties”), is made and entered into as of April 25, 2023, between the Original Parties and each of D1 Capital Partners Master LP, MIC Capital Management UK LLP, for and on behalf of funds, accounts and/or entities managed or advised by it, MIC Capital Management 38 RSC Ltd and 94th Investment Company LLC (each, a “New Party” and, collectively, the “New Parties”). Capitalized terms used herein but not otherwise defined shall have the meanings set forth in the Agreement.
Cazoo Group LtdViking Global Investors Lp • September 19th, 2022 • Retail-auto dealers & gasoline stations • New York
BOARD OBSERVER AND CONFIDENTIALITY AGREEMENTBoard Observer and Confidentiality Agreement • September 19th, 2022 • Viking Global Investors Lp • Retail-auto dealers & gasoline stations • New York
This Board Observer and Confidentiality Agreement (this “Agreement”), dated as of February 16, 2022, is made and entered into by and between Cazoo Group Ltd, a Cayman Islands exempted company (the “Company”), Viking Global Equities Master Ltd, a Cayman Islands exempted company (“VGEM”) and Viking Global Equities II LP, a Delaware limited liability company (“VGE2” and together with VGEM, the “Viking Investors”).
JOINT FILING AGREEMENTJoint Filing Agreement • September 19th, 2022 • Viking Global Investors Lp • Retail-auto dealers & gasoline stations
This joint filing agreement is made and entered into as of this 19th day of September, 2022, by and among VIKING GLOBAL INVESTORS LP, VIKING GLOBAL PERFORMANCE LLC, VIKING GLOBAL EQUITIES II LP, VIKING GLOBAL EQUITIES MASTER LTD., O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
BridgeBio Pharma LLC Lock-Up Agreement February 25, 2019Viking Global Investors Lp • July 8th, 2019 • Pharmaceutical preparations
The undersigned, currently an owner of membership interests in BridgeBio Pharma LLC, a Delaware limited liability company (the “LLC”), who will become an owner of equity interests in BridgeBio Pharma, Inc. as successor to the LLC (the “Company”), understands that you, J.P. Morgan Securities LLC (“J.P. Morgan”) and Goldman Sachs & Co. LLC (“Goldman Sachs”, and together with J.P. Morgan, the “Releasing Underwriters”), propose to enter into an Underwriting Agreement on behalf of the several Underwriters named in Schedule I to such agreement (collectively, the “Underwriters”), with the Company, providing for a public offering (the “Public Offering”) of the shares (the “Shares”) of the common stock of the Company, par value $0.01 per share (the “Common Stock”), pursuant to a Registration Statement on Form S-1 to be filed with the Securities and Exchange Commission (the “SEC”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 20th, 2023 • Viking Global Investors Lp • Pharmaceutical preparations
This joint filing agreement is made and entered into as of this 19th day of July, 2023, by and among VIKING GLOBAL INVESTORS LP, VIKING GLOBAL PERFORMANCE LLC, VIKING GLOBAL EQUITIES MASTER LTD., VIKING LONG FUND GP LLC, VIKING LONG FUND MASTER LTD., VIKING GLOBAL OPPORTUNITIES PARENT GP LLC, VIKING GLOBAL OPPORTUNITIES GP LLC, VIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC, VIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet.
